癌症表观遗传学:从实验室研究和临床试验到精准医学
Xinyang Yu1, Hao Zhao2, Ruiqi Wang3
1Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, (Zhuhai People's Hospital Zhuhai Clinical Medical College of Jinan University), Zhuhai, 519000, China.
Cell death discovery
|January 15, 2024
概括
表观遗传失调驱动许多疾病,特别是癌症. 表观遗传药物通过向这些可逆变化,为精确的癌症诊断和治疗提供了潜在的潜力.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 表观遗传失调是许多人类疾病的标志,尤其是癌症.
- 了解癌细胞表观遗传调节对于开发向疗法至关重要.
- 表观遗传变化伴随着瘤进展的所有阶段,包括复发.
研究的目的:
- 审查癌症表观遗传失调的机制.
- 讨论当前和历史上的表观遗传抑制剂用于癌症诊断和治疗.
- 探索基于表观遗传见解的精确癌症诊断和治疗的未来.
主要方法:
- 关于癌症表观遗传机制的文献综述.
- 对表观遗传药物开发和临床应用的分析.
- 综合目前对癌症表观遗传异常的理解.
主要成果:
- 表观遗传变化与瘤发生,促进,进展和复发有关.
- 表观遗传药物,特别是酶抑制剂,在癌症治疗中表现有前途.
- 技术进步加速了表观遗传生物标记物的识别.
结论:
- 与个性化医疗相结合的表观遗传疗法旨在利用生物标志物改善癌症风险评估,诊断和治疗.
- 进一步了解与癌症相关的表观遗传异常是推动精确诊断和治疗策略的关键.
- 表观遗传修饰是可逆的,是新型癌症干预措施的可行目标.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer
48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Mouse Models of Cancer Study
5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Cancer Survival Analysis
353
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
353


